TSS
BXRX

Two Sigma Securities’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Two Sigma Securities’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,014
Closed -$10K – 3513
2022
Q3 		$10K Buy
+1,014
New +$23.6K ﹤0.01% 2411
2022
Q2 		– Sell
-329
Closed -$23K – 3017
2022
Q1 		$23K Buy
329
+301
+1,075% +$55.6K ﹤0.01% 1962
2021
Q4 		$9K Buy
+28
New +$17.5K ﹤0.01% 1489

Other funds holding BXRX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SN
Sittner & Nelson Eugene, Oregon $274M AUM 22.46% 1-Year Est. Return

Two Sigma Securities's BXRX Position: Q4 2022 in Review

Two Sigma Securities sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q4 2022, closing a stake of 1,014 shares — an estimated $10K sold.

Two Sigma Securities first reported a position in BXRX in Q4 2021 and held it in 3 quarters. The position peaked at $23K in Q1 2022. 10 funds tracked by Wall St. Rank hold BXRX as of Q4 2022.

  • Two Sigma Securities reported no remaining Baudax Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 1,014 Baudax Bio, Inc. Common Stock shares in Q4 2022, an estimated $10K.
  • Two Sigma Securities first reported a position in Baudax Bio, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Two Sigma Securities's Baudax Bio, Inc. Common Stock position peaked at $23K in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.